how does glutathione s-transferase cause drug resistance in cancer cells Theta 2 causes by inhibiting arsenic trioxide-induced ferroptosis pancreatic ductal adenocarcinoma Simplified scheme of action of
Description
Disruptions in these rhythms are implicated in various eye diseases, highlighting the potential of circadian-targeted therapies to improve outcomes in conditions such as DED, glaucoma, retinal diseases, and cataracts
63 Current therapies for chronic hepatitis B (CHB) mainly use PEG-IFN and orally administered nucleotide analogs
EGCG has shown promise in reducing lipid accumulation and improving metabolic parameters in obesity-related conditions through mechanisms like increased fat oxidation, reduced lipogenesis, and enhanced energy expenditure
Changes in the blood flow through the brain and muscles during the arrest of breathing
The logic behind post-surgical use mirrors general injury recovery
